
Bio-Gene is an Australian #agtech company enabling the next generation of novel insecticides. Follow our journey. ASX: $BGT #NovelSaferBetter
Melbourne
Joined January 2021
- Tweets560
- Following197
- Followers399
- Likes476
Our Quarterly Activities Report for the period ending 30 September 2026 has been released.
View the full $BGT report: wcsecure.weblink.com.au/pdf/…
11
We've received $343,000 from the Australian Taxation Office under the Federal Government's Research and Development Tax Incentive program.
The cash incentive relates to R&D expenditure incurred during FY2026, supporting the development of our novel insecticides Flavocide® and Qcide® for use in global markets.
Tim Grogan, $BGT’s MD & CEO said: “The research and development tax incentive program is a very important Federal Government initiative that materially assists Bio-Gene Technology to undertake key technical activities to develop our products for use in global markets. The development of new insecticidal active compounds involves considerable research and development that is greatly assisted by this government support.”
Read more: wcsecure.weblink.com.au/pdf/…
$BGT #Flavocide #Qcide #ResearchAndDevelopment #BioInsecticides #InsecticideResistance
16
Bio-Gene’s Managing Director & CEO, Tim Grogan, was in Japan last week attending J-AGRI Tokyo 2026, one of Asia’s leading agriculture and livestock exhibitions, bringing together companies and industry professionals showcasing the latest agricultural technologies and products.
Japan is an important market for Bio-Gene as we progress our commercialisation strategy for Qcide®, our 100% natural insecticidal active derived from Australian Eucalyptus, including plans to develop a range of household insecticide products with Sumitomo Corporation and Nakashima Trading Co.
Events such as J-AGRI provide valuable industry insights and opportunities to strengthen our understanding of the markets we are targeting.
$BGT #JAGRI2026 #Japan #AgTech #NaturalInsecticides #PestManagement #SustainableAgriculture
30
Inside Biotech: Bio-Gene Technology’s Flavocide shows strong tick-control potential in Purdue University study | Media coverage by @proactive_au
tinyurl.com/mr334dja
36
We’ve had results from a study evaluating the efficacy of Flavocide® against Ixodes scapularis, also known as deer tick or blacklegged tick, published in the peer-reviewed journal Ticks and Tick-borne Diseases.
The preliminary assessment demonstrated potential for tick control, resulting in >90% mortality of Ixodes scapularis nymphs at 24 hrs post-exposure in contact assays and robust residual efficacy, with greater than 70% mortality up to four weeks, under laboratory conditions.
Ixodes scapularis transmits seven of the 19 tick-borne pathogens recognised in the US and is a major vector of Lyme disease. The study was conducted by researchers at Purdue University’s Department of Entomology under a vector control program funded by the US Centers for Disease Control and Prevention (CDC).
Publication of this data is an important milestone in Bio-Gene’s development of Flavocide as a novel bioactive ingredient for pest management, derived from nature. The results highlight its potential as a valuable new tool in integrated tick management strategies and justify further studies under laboratory conditions and in the field.
Read the full $BGT ASX Announcement here: wcsecure.weblink.com.au/pdf/…
#PestManagement #TickManagement #PublicHealth #LymeDisease #InsecticideResistance
24
Bio-Gene has been back on-site in Far North Queensland for another Qcide® harvest, with clear skies and dry conditions providing ideal conditions for harvesting both coppiced and newly planted trees.
Production continues to ramp up as we prepare to meet future market demand for Qcide oil, our 100% natural insecticidal active extracted from Eucalyptus cloeziana.
The latest harvest forms part of our ongoing work to expand Qcide production capability and support future commercial supply as we progress opportunities with partners in key markets.
$BGT #Qcide #NaturalInsecticides #BioInsecticides #PestManagement #AgTech #Queensland
127
Our 2026 Annual Report has been released for the year ended 30 June 2026.
View the full report: tinyurl.com/3wx379hp
#BGT #ASXNews $BGT
47
Our Quarterly Activities Report for the period ending 30 June 2026 has been released.
View the full report: wcsecure.weblink.com.au/pdf/…
#BGT #ASXNews $BGT
31
Congratulations to $BGT Executive Director, Research & Development, Peter May, on receiving the Envu Individual Excellence Professional Pest Management Award 2026 at the recent FAOPMA Pest Summit in Auckland, New Zealand.
The award recognises Peter's longstanding contribution to the professional pest management industry and reflects the strong relationships he has built across the sector over many years.
Peter's industry knowledge and connections are well aligned with Bio-Gene's strategy to develop the next generation of novel insecticides derived from nature. As Bio-Gene advances the commercial development of Qcide® and Flavocide®, these relationships continue to support the Company's objective of providing innovative products and technology to professional pest management companies to help protect people and the environment from pests and insect-borne diseases.
Congratulations Peter on this well-deserved recognition.
131
We’ve received applications under the 2026 Share Purchase Plan, with an underwriting agreement for up to $500,000 of funds raised under the SPP.
Proceeds raised from the SPP and recent Placement will be used to fund Flavocide®️ regulatory enabling studies, increasing production of Qcide®️, product development activities supporting the Company’s commercial partnering arrangements, strategic projects, general working capital and costs of the raise.
Flavocide regulatory enabling studies and increasing production of Qcide remain key priorities as Bio-Gene progresses the development of the next generation of novel insecticides derived from nature.
Read the full ASX Announcement here: wcsecure.weblink.com.au/pdf/…
$BGT #BioInsecticides #InsecticideResistance #AgTech #CropProtection
29
Join CEO & Managing Director Tim Grogan tomorrow at 9:30am AEST for an Investor Update Webinar covering the Company’s activities following the recent $3.27 million Placement and partially underwritten Share Purchase Plan.
The presentation will be followed by a live Q&A session.
📅 Thursday 4 June 2026
⏰ 9:30am AEST
Register here:
us02web.zoom.us/webinar/regi…
#BioGene #BGT #Flavocide #Qcide #AgTech #Biotech #InvestorWebinar
20
We’ve launched a Share Purchase Plan following the recent Placement, providing Eligible Shareholders the opportunity to acquire up to $15,000 in fully paid ordinary shares on the same terms as sophisticated and professional investors.
For every two shares issued under the SPP, participants will be granted one free attaching option, subject to shareholder approval.
Funds raised from the Placement and SPP will be used to fund Flavocide® regulatory enabling studies, increasing production of Qcide®, product development activities supporting commercial partnering arrangements, strategic projects and working capital.
Bio-Gene is now well advanced with the studies required to support the first application for regulatory approval of Flavocide as an active ingredient in Australia, while expanding Qcide production in advance of first product sales as part of its early pathway to market strategy.
Read the full $BGT ASX Announcement here: wcsecure.weblink.com.au/pdf/…
#BioGene #BGT #Flavocide #Qcide #Biotech #AgTech #Insecticides #Commercialisation #SharePurchasePlan
22
Bio-Gene Technology retweeted
🚨 *Raise Day Exclusive*: $BGT's Path Toward Commercialisation 🚀🌱
Greg sits down with Tim, MD & CEO of @biogenetechltd to discuss Flavocide® & Qcide®, insecticide resistance, upcoming catalysts & today’s capital raise. 🌱🦟📈
🎬 Watch Now: youtu.be/EfF_EizYDhQ
#ASX #BGT
We’ve raised $3.21 million via a Placement and Partially Underwritten Share Purchase Plan to support the remaining studies for Bio-Gene’s first Flavocide® regulatory dossier and the expanded production of Qcide® for supply to partners.
Funds raised will support Flavocide regulatory enabling studies, increasing production of Qcide, product development activities supporting commercial partnering arrangements, strategic projects and working capital.
The Company is targeting submission of its first application for regulatory approval of Flavocide active constituent in Australia in March 2027.
Tim Grogan, Managing Director & Chief Executive Officer for Bio-Gene, commented: “Funds raised in this Placement, and under the planned SPP, will be used to undertake the remaining safety studies required for Bio-Gene to submit our first application for regulatory approval of Flavocide® active constituent in Australia. Subsequently, achieving regulatory approval for Flavocide active constituent will be a key milestone in the execution of the Company’s strategy.
“In addition, this funding will enable Bio-Gene to increase production of Qcide®, undertake product development activities supporting our commercial partnering arrangements, various strategic projects and for working capital.
“We are very pleased to achieve this support from both new investors and our existing shareholders. This funding will enable us to continue to build momentum and accelerate our plans to commercialise both Flavocide and Qcide.”
Read the full $BGT #ASX Announcement here: wcsecure.weblink.com.au/pdf/…
#BioGene #BGT #Flavocide #Qcide #AgTech #Biotech #Insecticides #Regulatory #Commercialisation
23
Placement Investor Presentation - wcsecure.weblink.com.au/pdf/…
May 2026 $BGT
17
Bio-Gene is expanding evaluation of Flavocide® and Qcide® into Asia, testing their efficacy against mosquito species that spread Dengue fever, Chikungunya fever and Zika virus infection.
The initial phase of evaluation will follow World Health Organisation (WHO) guidelines and is anticipated to be completed by Q3 2026. Results will guide the commercialisation of both products for use in vector control programs across the region.
With mosquito resistance to currently available insecticides increasing, Flavocide® and Qcide® offer a novel mode of action — and both are derived from a sub-type of Eucalyptus cloeziana, which is native to Australia.
Read the full ASX announcement here: wcsecure.weblink.com.au/pdf/…
$BGT #BioGene #Flavocide #Qcide #VectorControl #Mosquito #Insecticides #AgTech #Biotech
36
We’ve received notice from the United States Patent & Trademark Office allowing a key patent for Flavocide® in synergistic combination with permethrin or pyrethrin.
Formal grant of the patent is expected during the next two to four months and will extend patent protection in the US to 2040.
Patents relating to these key insecticide combinations are already granted in Australia, Japan, New Zealand and in 22 member states of the African Regional IP Organisation (ARIPO).
Read the full $BGT #ASX Announcement here: wcsecure.weblink.com.au/pdf/…
#BioGene #Flavocide #Patent #IntellectualProperty #Insecticides #AgTech #Biotech
1
18
We’re at the mercy of insects and as CEO and MD Tim Grogan puts it, “they can access resistant strains of mosquitoes not by breeding them in the laboratory, but by simply opening the window.”
That reality is driving the need for new solutions, as resistance continues to reduce the effectiveness of many existing insecticides and pests are responsible for the loss of between 20 and 40% of food crops globally.
At Bio-Gene, we’re developing Flavocide® and Qcide®, derived from eucalyptus, targeting large markets across public health, agriculture, grain storage and consumer applications.
🎥 Watch the full presentation: youtu.be/y4v3hoaIjso
#BioGene #BGT #AgTech #Biotech #InsectResistance #FoodSecurity #MosquitoControl #Flavocide #Qcide #PestManagement #IgnitePartners
37
Our Quarterly Activities Report for the period ending 31 March 2026 has been released.
View the full $BGT report: wcsecure.weblink.com.au/pdf/…
35
















